BaoLaiTe Control Deal Is Called Off

Single-source brief: BaoLaiTe’s suspended control-change plan ended, and its shares fell to the daily limit.

What happened

BaoLaiTe, listed in Shenzhen as 300246.SZ, resumed trading on August 10.

Its proposed change in control was declared off, according to TMTPost.

Trading had been suspended for nearly a week. The plan had drawn market interest.

On resumption, BaoLaiTe shares fell by the 20% daily limit. The stock closed at 15.41 yuan per share.

TMTPost said large sell orders kept the stock at the limit-down level.

Business context

The company’s core business is hemodialysis equipment, TMTPost reported.

That business faces price pressure from centralized procurement, according to the publisher.

TMTPost also said growth in patient-monitoring equipment has peaked.

It reported that BaoLaiTe has posted losses for three straight years.

What remains unclear

The supplied evidence does not identify the proposed new controller. It also does not explain why the transaction ended.

No independent confirmation was provided in the packet.

This is a market and corporate-control event, not a verified robotics or AI deployment.